Survival impact of number of removed para-aortic lymph nodes in stage I epithelial ovarian cancer

[1] Desteli GA(2010)Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: hacettepe experience and review of literature World J Surg Oncol 8 106-65

[2] Gultekin M(2017)Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: a predictors- and nomogram-based analyses Gynecol Oncol 147 61-614

[3] Usubutun A(2011)Lymph node metastasis in stages I and II ovarian cancer: a review Gynecol Oncol 123 610-63

[4] Yuce K(2020)Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? Gynecol Oncol 160 56-90

[5] Ayhan A(2016)The impact of lymph node dissection and adjuvant chemotherapy on survival: a nationwide cohort study of patients with clinical early-stage ovarian cancer Eur J Cancer 66 83-15

[6] Bogani G(2018)Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer J Gynecol Oncol 29 e69-36

[7] Tagliabue E(2018)The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: a population-based study Int J Surg 52 11-244

[8] Ditto A(2013)Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer J Gynecol Oncol 24 29-540

[9] Signorelli M(2011)Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer Int J Gynecol Cancer 21 236-1414

[10] Martinelli F(2020)A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women BMC Cancer 20 1009-182

[1] Desteli GA(2010)Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: hacettepe experience and review of literature World J Surg Oncol 8 106-65

[2] Gultekin M(2017)Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: a predictors- and nomogram-based analyses Gynecol Oncol 147 61-614

[3] Usubutun A(2011)Lymph node metastasis in stages I and II ovarian cancer: a review Gynecol Oncol 123 610-63

[4] Yuce K(2020)Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? Gynecol Oncol 160 56-90

[5] Ayhan A(2016)The impact of lymph node dissection and adjuvant chemotherapy on survival: a nationwide cohort study of patients with clinical early-stage ovarian cancer Eur J Cancer 66 83-15

[6] Bogani G(2018)Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer J Gynecol Oncol 29 e69-36

[7] Tagliabue E(2018)The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: a population-based study Int J Surg 52 11-244

[8] Ditto A(2013)Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer J Gynecol Oncol 24 29-540

[9] Signorelli M(2011)Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer Int J Gynecol Cancer 21 236-1414

[10] Martinelli F(2020)A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women BMC Cancer 20 1009-182